Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026
Globe Newswire•20/10/2026•08:30 ET
0
Key Highlights
- ➤Q3 2026 financial results scheduled for October 27, 2026
- ➤Live webcast and conference call set for 8:30 a.m. ET
- ➤Wave Life Sciences (WVE) will provide business updates
- ➤Pipeline includes obesity, alpha-1 antitrypsin deficiency, and PNPLA3 programs
CAMBRIDGE, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, October 27, 2026, to review the company’s third quarter 2026 financial results and provide business updates.
The webcast and conference call may be accessed by visiting “Investor Events” on the investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events.
Get started
Create a free account to read the full story.